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Abstract 
BACKGROUND: Aneuploidy is a major cause of miscarriages and implantation failure. Preimplantation genetic 
testing for aneuploidy (PGT-A) by Next Generation Sequencing (NGS) is able to detect of the numeral and 
structural chromosomal abnormalities of embryos in vitro fertilization (IVF).  
AIM: This study was aimed to assess the relationship between maternal age and chromosomal abnormalities 
NGS technology.  
METHODS: A group of 603 human trophectoderm (TE) biopsied samples were tested by Veriseq kit of Illumina. 
The relation of marternal age and chromosomal abnormality of blastocyst embryo was evaluated. 
RESULTS: Among the 603 TE samples, 247 samples (42.73%) presented as chromosomal abnormalities. The 
abnormalities occurred to almost chromosomes, and the most popular aneuploidy observed is 22. Aneuploidy rate 
from 0.87% in chromosome 11 to 6.06% in chromosome 22. The rate of abnormal chromosome increased 
dramatically in group of mother's ages over 37 (54.17%) comparing to group of mother's ages less than 37 
(38.05%) (p < 0.000). The Abnormal chromosome and maternal age has a positive correlation with r = 0.4783 
(p<0.0001). 
CONCLUSION: These results showed high rate abnormal chromosome and correlated with advanced maternal 
age of blastocyst embryos. 
 
 
 
 
Introduction 
 
 Maximizing the success rate of in vitro 
fertilization (IVF) treatments is challenge, and a 
reliable mean of determining the embryos with the 
most significant capacity for pregnancy is required [1]. 
There are several molecular methods to assess 
embryos, which are available to be applied. The major 
cause of IVF failure was showed to be abnormal 
chromosome. Recent years, aneuploidy rates were 
higher in oocytes and embryos from women of 
advanced maternal age [2], [3], [4]. The number of 
women intentionally, delaying pregnancy after year-
old age of 35, has increased significantly last decades 
because the clash between the optimal biological 
period for women to have children and to obtain 
additional education, and building a career. In fact, for 
women over 40 years old, it is common for more than 
fifty percent of the oocytes retrieved to be aneuploidy 
[1], [5]. In miscarriage couples, an abnormal 
embryonic karyotype has been found to represent the 
most frequent cause [3]. 
 PGT-A has been applied for the last over ten 
years to assess the chromosome abnormality of 
embryos to satiate the reproductive outcome of 
specific patient groups. Aneuploidies are common in 
early human embryos such as day 3 to day 5. Most 
methodologies of embryo assessment involve 
morphologic analysis at different developmental 
stages of the embryo. Blastomere number, multi-
nucleation, fragmentation of embryo, and blastocyst 
formation are the key factors associated with viability 
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of embryo. The relationship between morphology and 
embryo aneuploidy was first evaluated with 
Fluorescence in situ hybridization (FISH) studies for 
7–8 chromosomes [6]. Pellicer’s experience showed 
that a remarkable rate of embryos with chromosomal 
abnormality was able to develop to the blastocyst with 
suitable morphology parameters; in fact, 42.8% of 
chromosomally abnormal embryos reached blastocyst 
stage [7]. However, the failure of finding a better 
morphologic indicator of aneuploidy in previous 
researches had been a consequence of technical 
insufficiency. Virtually all study has evaluated only a 
few specific chromosomes in each embryo, and it is 
therefore unavoidable that some of the embryos 
categorized as aneuploidy were, in fact, abnormal, 
with aneuploidies affecting chromosomes that were 
not tested [1]. 
 More recently, in a study, array comparative 
genomic hybridization (A- CGH) could be used to 
detect 24 embryonic chromosomes. A-CGH was the 
first technology to be widely available for 
comprehensive aneuploidy screening and is now used 
extensively around the world [8]. The rapid 
development of next generation sequencing (NGS) 
technologies has generated an increasing interest to 
apply in PGT-A purposes and the technique offer 
improvements for the detection of chromosomal 
aneuploidy in IVF embryos compared with current 
technologies by reduced costs and enhanced 
precision as well as parallel and customizable 
analysis of multiple embryos in a single sequencing 
run [8], [9]. In this study, we applied NGS technology 
to screening 24-chromosome aneuploidy on embryos 
at blastocyst stages. This approach with 
trophectoderm samples from blastocyst biopsies, both 
whole chromosome aneuploidy and segmental 
chromosome imbalances would be detected. We also 
determined the chromosomal abnormalities of 
blastocyst-stage embryos in vitro fertilization using 
PGS-NGS technique and evaluating the correlation 
between the chromosomal status of blastocyst-stage 
embryos and the maternal age. 
 
 
 
Materials and Methods 
 
 Material 
 The study population consisted of 603 
embryos from consecutive patients planning to 
undergo PGS with trophectoderm (TE) biopsy. All IVF 
cycles were performed at the Andrology and Fertility 
Hospital of Hanoi, and Hanoi Hospital of Obstetrics 
and Gynecology in the period between June 2017 and 
February 2018. Genetic testing was performed at the 
DNA laboratory - Vietnam Military Medical Academy. 
 
 
 Whole genome amplification (WGA) 
 For whole genome amplification, TE samples, 
negative and positive controls were lysed, and 
genomic DNA was amplified by SurePlex kit (Illumina, 
Inc., San Diego, CA, USA), as the manufacturer's 
recommendation. Then, 5 µl of each product plus 5 µl 
gel loading dye were tested by agarose 
electrophoresis to determine the success of the 
amplification. 
 
 Libraries preparation 
 Libraries were prepared at DNA Lab using the 
VeriSeq PGS workflow (Illumina, Inc.), was briefly 
following: One nanogram of quantified dsDNA 
template at 0.2 ng/ml was added to 5 µl of Amplicon 
Tagmentation Mixture (ATM) and 10 µl of 
Tagmentation DNA Buffer (TD). The segmentation 
step was carried out at 55
o
C for 5 min and hold at 
10
o
C. The resulting segmented mixture was 
neutralized by adding 5µl of proprietary neutralization 
buffer (NT). Post-homogenization, the Tagmentation 
plate was held at room temperature for 5 min. The 
fragmented DNA was amplified via a limited-cycle 
PCR programme (one cycle of 72
o
C for 3 min, 
followed by 12 cycles of 95
o
C for 10 s, 55
o
C for 30 s 
and 72
o
C for 30 s, one cycle at 72
o
C for 30 s, followed 
by a hold at 4
o
C) after the adding of 5µl of index 1 (i7), 
5µl of index 2 (i5), and 15µl of Nextera PCR Master 
Mix (NPM) to each well. PCR product clean-up used 
AMPureXP beads (Beckman Coulter, Brea, CA, USA) 
to purify the library DNA with no salt carryover, 
providing a size selection step that removes short 
library fragments including index 1 (i7) and index 2 (i5) 
from the population. 45 µl of the PCR product was 
transferred to 96-well storage plates containing 45 µl 
of AMPure XP beads. Sealed plates were mixed using 
a microplate shaker at 1000 rpm for 2 min, then 
incubated at ambient temperature without shaking for 
5 min. Thereafter, the plate was placed on a magnetic 
stand for 2 min or until the supernatant cleared. While 
the plates were kept on the magnetic stand, the 
magnetic beads were washed twice with 200 µl of 
freshly prepared 80% ethanol. Purified libraries were 
eluted with 50 µl of the Nextera XT Resuspension 
Buffer. It could be found more detail elsewhere [8], [9]. 
  
 Sequencing 
 Single-end, dual index 36 base pair reads 
sequencing was performed at DNA Laboratory 
following the Illumina chemistry workflow on a MiSeq 
(Illumina, Inc.), using the MiSeq Reagent Kit v3 PGS 
kit (Illumina, Inc.) which contains the ready to load 
onboard clustering and SBS chemistry reagents.  
 
 Processing and analysing data 
 The following bioinformatics analysis was 
accomplished with a pre-release version of BlueFuse 
Multi for NGS (Illumina, Inc.). "Embryos were 
diagnosed as "euploidy" if the generated plot showed 
no gain or loss [8]. Secondary analysis included 
statistics; description, processing, and data analysis 
were performed by STATA software version 14. We 
compared the average values by t-testst and the 
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ratios by Chi quare test, CI 95%. We use simple linear 
regression and Pearson's correlation to find the 
relationship. 
 
 
Results 
 
 Of the blastocyst-stage embryos, 95.9% were 
succeeding in whole genome amplification (578 out of 
603). We investigated 410 embryos belong group 
mother’s age <37 years old Group 1 (32.6 ± 3.43) and 
168 embryos belong group mother’s age >37 years 
old – Group 2 (39.63 ± 2.96) (Table 1).  
Table 1: PGS-NGS results in 578 embryos at blastocyst stage, 
(Pearson chi2(1) = 12.6506 pr = 0.000) 
  
Group 1 
(<37 years old) 
Group 2 
(≥37 years old) 
Total 
P 
(Group 1 vs 
Group 2) 
Average age (Mean±SD 32.06 ± 3.43 39.63 ± 2.96 34.26 ± 4.76 0.0000 
Normal embryos (n, %) 
254 
61.95% 
77 
45.83% 
331 
57.27% 
0.0000 
Abnormal embryo (n, %) 
156 
38.05% 
91 
54.17% 
247 
42.73% 
0.0000 
Total embryo (n, %) 
410 
100% 
168 
100% 
578 
100% 
 
Note: P values were determined by t test and Chi square test. 
 
 A wide variety of aneuploidies was detected. 
Indeed, the results showed that any chromosome can 
be affected by aneuploidy at the blastocyst stage. A 
total of 322 chromosomal abnormalities were detected 
in the aneuploidy embryos represented monosomy, 
trisomy (Figure 1). Top 3 chromosomal 22, 16 and 21 
were much more represented by abnormal than 
others (35, 32 and 24, respectively) (Table 2).  
Table 2: Characteristics of aneuploidy 
Chrom-
osome 
Total 
chromosome 
tested 
Aneuplody  Euploidy 
n % n % 
1 578 9 1.56% 569 98.44% 
2 578 11 1.90% 567 98.10% 
3 578 12 2.08% 566 97.92% 
4 578 15 2.60% 563 97.40% 
5 578 13 2.25% 565 97.75% 
6 578 9 1.56% 569 98.44% 
7 578 7 1.21% 571 98.79% 
8 578 17 2.94% 561 97.06% 
9 578 6 1.04% 572 98.96% 
10 578 17 2.94% 561 97.06% 
11 578 5 0.87% 573 99.13% 
12 578 12 2.08% 566 97.92% 
13 578 15 2.60% 563 97.40% 
14 578 10 1.73% 568 98.27% 
15 578 19 3.29% 559 96.71% 
16 578 32 5.54% 546 94.46% 
17 578 10 1.73% 568 98.27% 
18 578 11 1.90% 567 98.10% 
19 578 7 1.21% 571 98.79% 
20 578 8 1.38% 570 98.62% 
21 578 24 4.15% 554 95.85% 
22 578 35 6.06% 543 93.94% 
XY 578 18 3.11% 560 96.89% 
Total 13294 322 2.42% 12972 97.58% 
 
 As expected, a strong association between 
advancing maternal age and aneuploidy was 
observed, but interestingly individual chromosomes 
were not equally affected by this phenomenon. There 
were 54.1% embryos had chromosomal abnormality 
in group 1 whereas only 38.05% in Group 1 (Table 1). 
 
Figure 1: Examples of chromosomal abnormalities detection by 
next-generation sequencing. Embryo number HU3 of patient N. T. 
H.: 42, XY, -2, -5, -6, -22, +4 
 
  
 Results from the embryos of group 1 were 
compared with those from patients in group 2. 
Chromosome 14 showed the greatest increase in the 
risk of aneuploidy (3.7-fold increase). Chromosomes 7 
and 18 displayed a 3.3 and a 2.9-fold increase, 
respectively. For chromosomes 2, 3, 12, 13, 15, 17, 
19, 20, 21 and 22 the increase was around from 1.5 to 
2-fold. Other chromosomes were found little or no 
change in aneuploidy rate with advancing age (Figure 
2). 
 
Figure 2: Incidence of chromosomal abnormalities between two 
groups 
 
 We evaluated the relationship between 
blastocyst-stage chromosomal abnormalities and 
maternal age using linear regression and Pearson's 
correlation (Figure 3). The correlation coefficients r = 
0.4783 (CI 95%) are illustrated as formula: 
Abnormalities probity of chromosomes = -0.7 + 0.01 x 
(maternal age) 
 
 
Figure 3: The linear regression line shows the correlation between 
maternal age and the rate of aneuploidy. R
2
: coefficient index 
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Discussion 
 
 The evaluation of genetic normality embryo is 
the most important criterion for the selection of 
embryos to be transferred. Thus, the present study 
attempted to re-evaluate previous studies that had 
described the relationship between chromosome 
abnormalities and maternal age using newest PGS 
method based on NGS technology [10], [11], [12], 
[13], [14], [15]. The analysis of more than 603 
embryos for 23 chromosome pairs makes this study 
the most extensive and comprehensive to date on 
chromosome abnormalities in human cleavage stage 
embryos.  
 In this study showed that the abnormal 
chromosomal IVF in Vietnam population was 42.7% 
(Confident interval 95%). This number indicated with 
Rubio’s study in 2003 analyzing similar maternal age 
that there were 45.1% embryo had abnormal 
chromosomal [16]. In 2003, Alfarawati showed that 
there was more than half of embryos tested had 
abnormal (56.7%) [17]. However, their study focused 
on recurrent miscarriage and high maternal age 
(average 37.5 years) whereas this study focused on 
patient had average age lower (34.4 years). In 1991, 
Zenzes and Casper represented the rate of 
abnormalities in embryo was fluctuate from 23% to 
40% [18]. It is possible to project used NGS method 
with high accuracy compare with karyotyping used by 
Zenzes.  
 Aneuploidy is the most error observed on the 
embryo at the blastocyst stage [19]. Notably, the 
proportion of each chromosome is the difference in 
order that testing individual chromosomal or some 
chromosomes was concluded healthy embryo due to 
an increasing false negative. Therefore, the high 
aneuploidy rates observed suggest that chromosome 
screening at the blastocyst stage may be beneficial, 
particularly for women >34 years [20]. 
 On the other hand, the results agreed with 
previous trends, such as that aneuploidy increases in 
cleavage stage embryos with maternal age. It is clear 
that maternal age is only one of the causes of 
chromosome abnormalities. The present study 
confirms that only 61.95% of embryos from young 
patients are healthy for the chromosomes studied (< 
37 years), and this frequency decreases to 45.83% 
with advancing maternal age (>37 years) (CI: 95%, p 
< 0.05). In 2003, Rubio’s study illustrated that the 
abnormalities rate of chromosomes were 33.3% at 
patients age <37 years and increased to 57.7% at 
patients age >37 years [16]. Of research made, 
Aneuploidy reached over 50% with maternal age >40 
years [20]. In addition, in the year 2017, Upadhyaya 
concluded that the number of normal embryos in 
group < 37 years was 65.5% and fallen at 40.6% 
when maternal age increasing [21]. This proportion for 
this study was very similar to the proportion of our 
study. Even Upadhyaya et al. used another 
technology (array CGH) to detected comprehensive 
chromosomes.  
 The results make us believe that 
chromosomal abnormalities of the embryo in IVF 
blastocyst stage have a relationship with maternal 
age, although the correlation coefficient is not really 
high (r = 0.4783, CI:95%). In fact, this coefficient is 
positive, that means the higher the mother's age will 
have more chromosomal abnormalities of embryos. 
Figure 3 shows that each 22.87% variation in the 
incidence of chromosome abnormalities is explained 
by the variation of maternal age factor (coefficient of 
determination R-square = 0.2287). When maternal 
age increases by one unit, the incidence of 
chromosome numbers increases by 0.01 units, and 
this change is significant, with 95% confidence [22]. 
 Overall, the probability of embryo aneuploidy 
increases when maternal age higher. This effect 
becomes more impressive for some chromosomes. 
The chromosome most affected by age is 
chromosome 14; the data show that the rate of 
multiple deviations increased by 3.7 times in the 
elderly group (≥ 37 years). Then came chromosome 
7, the rate of multiple deviations increased by 3.3 
times and chromosome 18 increased by 2.9 times 
when the mother's age increased compared with the 
average increase of about 1.5 to 2 times for all 
chromosomes 2, 3, 12, 13, 15, 17, 18, 19, 20, 21, 22. 
In addition to the study of Alfarawati and colleagues in 
2011, chromosomes 7 and 14 were the most 
prevalent group with the highest increase in maternal 
age (5-6 times higher), and for infection chromosomes 
2, 15, 17, 20, 22 doubled [17]. This conclusion is quite 
similar to our results, thus confirming the reliability of 
this study. 
 In conclusion, the rate of chromosomal 
abnormalities of embryos at blastocyst stage in vitro 
fertilization in the Vietnamese population is 42.7%. 
The most common groups of chromosomes were 
observed including chromosome number 15, 16, 21, 
22 and sex chromosomes.  
 The proportion of embryos with abnormal 
chromosome and maternal age has a positive 
correlation with the average level of contact (r = 
0.4783), meaning that the higher the age of the 
mother will make greater the risk of creating embryos 
have chromosomal abnormalities. 
 
 
Ethical approval 
 
 All procedures performed in studies involving 
human participants were in accordance with the 
ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable 
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ethical standards. This study was approved by the 
ethics committee Vietnam Military Medical University. 
 
 
Informed consent 
 
 The informed consents were signed by 
patients. 
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